Bank of America
TXMD icon

Bank of America’s TherapeuticsMD TXMD Stock Holding History

Bank of America’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-108
Closed -$176 – 6841
2025
Q4 		$176 Buy
108
+2
+2% +$3 ﹤0.01% 6724
2025
Q3 		$114 Sell
106
-414
-80% -$464 ﹤0.01% 7830
2025
Q2 		$603 Buy
520
+22
+4% +$27 ﹤0.01% 7629
2025
Q1 		$461 Buy
498
+4
+0.8% +$4 ﹤0.01% 7533
2024
Q4 		$425 Hold
494
– – ﹤0.01% 7438
2024
Q3 		$820 Buy
494
+7
+1% +$12 ﹤0.01% 7286
2024
Q2 		$784 Buy
487
+87
+22% +$176 ﹤0.01% 7274
2024
Q1 		$916 Sell
400
-9
-2% -$21 ﹤0.01% 7211
2023
Q4 		$920 Sell
409
-8,101
-95% -$19.5K ﹤0.01% 7214
2023
Q3 		$25.7K Buy
8,510
+8,110
+2,028% +$30.7K ﹤0.01% 6671
2023
Q2 		$1.65K Sell
400
-176
-31% -$691 ﹤0.01% 7173
2023
Q1 		$2.16K Sell
576
-205
-26% -$984 ﹤0.01% 7208
2022
Q4 		$4.37K Sell
781
-862
-52% -$5.08K ﹤0.01% 7082
2022
Q3 		$12K Sell
1,643
-73,584
-98% -$596K ﹤0.01% 7194
2022
Q2 		$748K Buy
75,227
+69,838
+1,296% +$667K ﹤0.01% 5152
2022
Q1 		$102K Sell
5,389
-2,201
-29% -$34.6K ﹤0.01% 6853
2021
Q4 		$135K Buy
7,590
+1,886
+33% +$56.5K ﹤0.01% 6721
2021
Q3 		$211K Buy
5,704
+4,513
+379% +$200K ﹤0.01% 6275
2021
Q2 		$71K Sell
1,191
-3,193
-73% -$193K ﹤0.01% 6681
2021
Q1 		$294K Buy
4,384
+3,707
+548% +$290K ﹤0.01% 5769
2020
Q4 		$41K Sell
677
-215
-24% -$14.7K ﹤0.01% 6396
2020
Q3 		$70K Sell
892
-789
-47% -$62.9K ﹤0.01% 5858
2020
Q2 		$105K Buy
1,681
+537
+47% +$31.3K ﹤0.01% 5642
2020
Q1 		$61K Sell
1,144
-880
-43% -$87.3K ﹤0.01% 5784
2019
Q4 		$245K Sell
2,024
-1,946
-49% -$280K ﹤0.01% 5495
2019
Q3 		$721K Sell
3,970
-35,183
-90% -$4.96M ﹤0.01% 4809
2019
Q2 		$5.09M Buy
39,153
+36,277
+1,261% +$6.5M ﹤0.01% 3218
2019
Q1 		$701K Buy
2,876
+142
+5% +$37.6K ﹤0.01% 4787
2018
Q4 		$521K Buy
2,734
+1,198
+78% +$292K ﹤0.01% 4901
2018
Q3 		$504K Buy
1,536
+350
+30% +$107K ﹤0.01% 4939
2018
Q2 		$370K Sell
1,186
-552
-32% -$169K ﹤0.01% 5070
2018
Q1 		$424K Buy
1,738
+728
+72% +$204K ﹤0.01% 4938
2017
Q4 		$305K Buy
1,010
+479
+90% +$133K ﹤0.01% 5213
2017
Q3 		$141K Buy
531
+493
+1,297% +$143K ﹤0.01% 5539
2017
Q2 		$9K Sell
38
-1,276
-97% -$320K ﹤0.01% 6463
2017
Q1 		$473K Sell
1,314
-456
-26% -$141K ﹤0.01% 4918
2016
Q4 		$511K Buy
1,770
+1,609
+999% +$499K ﹤0.01% 4785
2016
Q3 		$55K Sell
161
-48
-23% -$17.5K ﹤0.01% 5694
2016
Q2 		$88K Buy
209
+126
+152% +$51.9K ﹤0.01% 5582
2016
Q1 		$26K Sell
83
-186
-69% -$63.5K ﹤0.01% 6039
2015
Q4 		$140K Buy
269
+130
+94% +$48K ﹤0.01% 5575
2015
Q3 		$40K Sell
139
-341
-71% -$121K ﹤0.01% 6035
2015
Q2 		$189K Buy
480
+473
+6,757% +$167K ﹤0.01% 5264
2015
Q1 		$2K Sell
7
-135
-95% -$33K ﹤0.01% 6707
2014
Q4 		$32K Sell
142
-33
-19% -$6.81K ﹤0.01% 6572
2014
Q3 		$41K Sell
175
-135
-44% -$34K ﹤0.01% 6642
2014
Q2 		$68K Buy
310
+252
+434% +$56.1K ﹤0.01% 6423
2014
Q1 		$18K Buy
58
+8
+16% +$2.55K ﹤0.01% 6963
2013
Q4 		$13K Sell
50
-69
-58% -$15.1K ﹤0.01% 7199
2013
Q3 		$17K Sell
119
-2,372
-95% -$287K ﹤0.01% 6953
2013
Q2 		$377K Buy
+2,491
New +$341K ﹤0.01% 5014

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America's TXMD Position: Q1 2026 in Review

Bank of America sold out of TherapeuticsMD (TXMD) in Q1 2026, closing a stake of 108 shares — an estimated $176 sold.

Bank of America first reported a position in TXMD in Q2 2013 and held it in 51 quarters. The position peaked at $5.09M in Q2 2019. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

  • Bank of America reported no remaining TherapeuticsMD position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 108 TherapeuticsMD shares in Q1 2026, an estimated $176.
  • Bank of America first reported a position in TherapeuticsMD in Q2 2013 and held it in 51 quarters.
  • Bank of America's TherapeuticsMD position peaked at $5.09M in Q2 2019.
  • 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.